Search - tctmd.com

Displaying 781 - 800 of 1372

Sort: Relevancy | Date

Presentation TCT 2019

Unexpected Shock: Where Does It Come From?

Presenter: Merida Cardenas Manilla

September 27, 2019

Presentation TCT 2019

Unusual Situation During Transradial Intervention

Presenter: Purich Surunchuakorn

September 27, 2019

Presentation TCT 2019

No Reflow After Balloon Angioplasty

Presenter: Cheng Han Lee

September 27, 2019

Presentation TCT 2019

'Til Death Do Us Tear Apart

Presenter: Aaron Wong Sung Lung

September 27, 2019

Presentation TCT 2019

Introduction

Presenter: Michael Haude

September 27, 2019

Presentation TCT 2019

PFO in 2019, A Neurologist’s Perspective

Presenter: David Thaler

September 27, 2019

Presentation TCT 2019

Revascularization in Stable CAD: What Do the New 2019 ESC Guidelines Recommend?

Presenter: Jean Fajadet

September 27, 2019

Presentation TCT 2019

Emerging Safety Signals and FDA’s Medical Device Safety Action Plan: Responses to the Late Mortality Signal

Presenter: Rebecca Ward

September 26, 2019

Presentation TCT 2019

Potential Study Designs to Address the Mortality Safety Signal

Presenter: Laura Mauri

September 26, 2019

Presentation TCT 2019

LV Unloading to Reduce Infarct Size: Rationale, Completed Studies, and Ongoing Trials

Presenter: Navin Kapur

September 26, 2019

Presentation TCT 2019

LV Unloading to Reduce Infarct Size: Rationale, Completed Studies, and Ongoing Trials

Presenter: Navin Kapur

September 26, 2019

Presentation TCT 2019

Informed Consent and Impact on Clinical Practice: A Clinician’s Perspective and a Pathway Forward

Presenter: Sahil Parikh

September 26, 2019

Presentation TCT 2019

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

Presenter: Gregg Stone

September 26, 2019

Presentation TCT 2019

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Presenter: Ian Meredith AM

September 26, 2019

Presentation TCT 2019

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

Presenter: Elazer Edelman

September 26, 2019

Presentation TCT 2019

No Reflow: How to Prevent It and How to Fix It!

Presenter: Mitul Patel

September 26, 2019

Presentation TCT 2019

Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data

Presenter: Krishna Rocha-Singh

September 26, 2019

Presentation TCT 2019

New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated)

Presenter: Konstantinos Katsanos

September 26, 2019

Presentation TCT 2019

A Woman’s Perspective!: Minoca, SCAD, Takotsubo, etc.

Presenter: Jacqueline Saw

September 26, 2019

Presentation TCT 2019

STEMI 2019: Who Are the High-Risk Patients?

Presenter: Andreas Baumbach

September 26, 2019

Advertisement

Unexpected Shock: Where Does It Come From?

Unusual Situation During Transradial Intervention

No Reflow After Balloon Angioplasty

'Til Death Do Us Tear Apart

Introduction

PFO in 2019, A Neurologist’s Perspective

Revascularization in Stable CAD: What Do the New 2019 ESC Guidelines Recommend?

Emerging Safety Signals and FDA’s Medical Device Safety Action Plan: Responses to the Late Mortality Signal

Potential Study Designs to Address the Mortality Safety Signal

LV Unloading to Reduce Infarct Size: Rationale, Completed Studies, and Ongoing Trials

LV Unloading to Reduce Infarct Size: Rationale, Completed Studies, and Ongoing Trials

Informed Consent and Impact on Clinical Practice: A Clinician’s Perspective and a Pathway Forward

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

No Reflow: How to Prevent It and How to Fix It!

Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data

New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated)

A Woman’s Perspective!: Minoca, SCAD, Takotsubo, etc.

STEMI 2019: Who Are the High-Risk Patients?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content